The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 16, 2022

Filed:

Mar. 16, 2020
Applicants:

Beta Pharma, Inc., Wilmington, DE (US);

Beta Pharma (Shanghai) Co., Ltd., Shanghai, CN;

Inventors:

Jirong Peng, Mequon, WI (US);

Michael John Costanzo, Warminster, PA (US);

Michael Nicholas Greco, Lansdale, PA (US);

Michael Alan Green, Easton, PA (US);

Victoria Lynn Wilde, Montclair, NJ (US);

Don Zhang, Princeton, NJ (US);

Assignees:

BETA PHARMA INC., Princeton, NJ (US);

BETA PHARMA (SHANGHAI) CO., LTD., Shanghai, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 403/04 (2006.01); C07D 401/14 (2006.01); C07D 471/04 (2006.01); C07D 403/14 (2006.01); A61K 31/506 (2006.01); A61K 45/06 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01);
U.S. Cl.
CPC ...
C07D 403/04 (2013.01); A61K 31/506 (2013.01); A61K 45/06 (2013.01); C07D 401/14 (2013.01); C07D 403/14 (2013.01); C07D 471/04 (2013.01);
Abstract

This application discloses novel substituted 2-anilinopyrimidine derivatives, and pharmaceutically acceptable salts, solvates, prodrugs, and compositions thereof, which are useful for the treatment or prevention of diseases or medical conditions mediated by epidermal growth factor receptors (EGFRs), including but not limited to a variety of cancers.


Find Patent Forward Citations

Loading…